"Children younger than 24 months of age with CHD who are most likely to benefit from immunoprophylaxis include:
- infants who are receiving medication to control congestive heart failure;
- infants with moderate-to-severe pulmonary hypertension; and
- infants with cyanotic heart disease."
dx.doi.org/10.1542/peds.2...
- infants who are receiving medication to control congestive heart failure;
- infants with moderate-to-severe pulmonary hypertension; and
- infants with cyanotic heart disease."
dx.doi.org/10.1542/peds.2...
Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.
Cancel
Endorsed by
,
more...
Private
only
only
Mar 20, 2013
Criteria guidelines for prophylaxis from American Academy of Paediatrics
dx.doi.org/10.1542/peds.2...
dx.doi.org/10.1542/peds.2...
Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.
Cancel
Endorsed by
,
more...
Private
only
only
Mar 20, 2013